Palatin Technologies (PTN) Other financing activities (2014 - 2026)
Palatin Technologies' (PTN) quarterly Other financing activities came in at $139510.0 in Q1 2026, up 65091.59% on a YoY basis from N/an in Q1 2025, and down 87.66% quarter-over-quarter from $1.1 million in Q4 2025.
Analysis
Palatin Technologies (PTN) Other financing activities (2014 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported Other financing activities for 8 consecutive years, with $139510.0 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 65091.59% year-over-year to $139510.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 746835.51% YoY), and the FY2025 full-year result was $3.4 million, down 43.79% from the prior year.
- Other financing activities eased to $139510.0 in Q1 2026 per PTN's latest filing, from $1.1 million in the prior quarter.
- Across five years, Other financing activities topped out at $1.1 million in Q4 2025 and bottomed at $78.0 in Q1 2023.
- Historically, Other financing activities has averaged $319746.8 across 3 years, with a median of $139510.0 in 2026.
- The widest YoY moves for Other financing activities: up 65091.59% in 2026, down 65091.59% in 2026.
- Over 3 years, Other financing activities stood at $78.0 in 2023, then jumped by 1449556.41% to $1.1 million in 2025, then tumbled by 87.66% to $139510.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $139510.0, $1.1 million, and $328200.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 139,510.00 |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 328,200.00 |
| Mar 31, 2025 | 214.00 |
| Mar 31, 2023 | 78.00 |
| Jun 30, 2019 | 808,934.00 |
| Jun 30, 2018 | 2.40 Mn |
| Sep 30, 2017 | 114,384.00 |
| Jun 30, 2017 | 50,000.00 |
| Mar 31, 2017 | 114,358.00 |
| Jun 30, 2015 | 50,000.00 |
| Jun 30, 2014 | 37,500.00 |